Dr. Omar H. Llaguna, specialist in surgical oncology, programs a HistoSonics medical device for targeting a medium that ...

Sarcoma: The aggressive cancer you’ve probably never heard of - Sarcoma is a less recognised, but aggressive form of cancer ...

Calviri, Inc, a company focused on ending cancer in dogs and people, announces the publication of High-sensitivity ...

DelveInsight’s, “Systemic Mastocytosis Pipeline Insight, 2025,” report provides comprehensive insights about 8+ companies and ...

CAR-T cells are specialized immune cells genetically modified to recognize and attack cancer cells. Researchers at Nagoya ...

Mast cell tumors (MCT) are the most common type of skin tumor in dogs. These cancerous tumors consist of the mast cells that give them their name. About 20 percent of skin tumors in our canine ...

Although SM is characterized by excessive mast cell burden and activation, the conventional pharmacologic approach of oral histamine receptor blockade fails to counteract the profound histamine burden ...

Clinically meaningful anti-tumor activity of ZL-1310 observed in heavily pretreated population of patients with small cell lung cancer (SCLC) across dose escalation and expansion cohorts - In ...